Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Brentuximab Vedotin and Nivolumab for Relapsed or Refractory Classic Hodgkin Lymphoma: Long-Term Follow-up Results from the Single-Arm Phase 1/2 Study

Alison J. Moskowitz, MD, Ranjana H Advani, MD, Nancy L. Bartlett, MD, Julie M Vose, MDMBA, Radhakrishnan Ramchandren, MD, Tatyana A. Feldman, MD, Ann S. LaCasce, MD MMSc, Beth A. Christian, MD, Stephen M Ansell, MD PhD, Craig H. Moskowitz, Lisa Brown, David Taft, Sahar Ansari, Daniel E. Zak, PhD, Mariana Sacchi, MD, Thomas Manley, MD, Alex F. Herrera, MD

Blood (2019) 134 (Supplement_1): 238.

https://doi.org/10.1182/blood-2019-122576

Published: 2019

Journal Articles

Results of a Phase I Study of Obinutuzumab, Venetoclax, and Lenalidomide in Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma

Beth A. Christian, MD, Ying Huang, MS, MA, Sabarish Ayyappan, MBBS, Robert A Baiocchi, MD PhD, Jonathan E Brammer, MD, Narendranath Epperla, MDMS, Samantha Jaglowski, MDMPH, Basem M. William, MRCP,MD, Farrukh T. Awan, MD, Kami J. Maddocks, MD, Kristie A. Blum, MD

Blood (2019) 134 (Supplement_1): 4082.

https://doi.org/10.1182/blood-2019-126242

Published: 2019

Journal Articles

A Phase I Study of Nivolumab and Lenalidomide in Relapsed/ Refractory B Cell Lymphoma

David A. Bond, MD, Vedat Yildiz, Lai Wei, PhD, Lapo Alinari, MD PhD, Basem M. William, MRCP,MD, Jonathan E. Brammer, MD, Beth A. Christian, MD, Kristie A. Blum, MD, Kami J. Maddocks, MD

Blood (2019) 134 (Supplement_1): 4091.

https://doi.org/10.1182/blood-2019-130539

Published: 2019

Journal Articles

Brentuximab Vedotin (BV) and Lenalidomide (Len) in Relapsed and Refractory (r/r) Cutaneous (CTCL) and Peripheral (PTCL) T-Cell Lymphomas; A Planned Interim Analysis of Phase II Trial

Basem M. William, MRCP,MD, Ying Huang, MS, MA, Amy Johnson, MD, Jonathan E Brammer, MD, John C. Reneau, MD PhD, Joseph Maakaron, MD, Ruth Larbi, Cara Grantier, CNP, MPH, MS, Corinne Hoffman, MS, CNP, Sabarish Ayyappan, MBBS, Robert A Baiocchi, MD PhD, Narendranath Epperla, MDMS, Beth A. Christian, MD, Lapo Alinari, MD PhD, Kami J. Maddocks, MD, Catherine Chung, MD

Blood (2019) 134 (Supplement_1): 2853.

https://doi.org/10.1182/blood-2019-123801

Published: 2019

Journal Articles

Preliminary Results of a Phase I Study of Obinutuzumab, Venetoclax, and Lenalidomide in Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma

Kami J. Maddocks, MD, Farrukh T. Awan, MD MS, Ying Huang, MA, MS, Sabarish Ayyappan, MBBS, Robert A Baiocchi, MD PhD, Narendranath Epperla, MD MS, Samantha Jaglowski, MD MPH, Basem M. William, MRCP, MD, Kristie A. Blum, MD, Beth A. Christian, MD

Blood (2018) 132 (Supplement 1): 4185.

https://doi.org/10.1182/blood-2018-99-117172

Published: 2018

Journal Articles

Management of Relapse in Acute Promyelocytic Leukemia Treated with Upfront Arsenic Trioxide Based Regimens

Fouzia N., DNB, DM, Vibhor Sharma, MDDM, Anu Korula, MBBS, MD DM, Anup Joseph Devasia, MD DM, Uday Prakash Kulkarni, MD DM, Yasir Jeelani Samoon, MDDM, Thenmozhi Mani, PhD, Jeyaseelan Lakshmanan, PhD, Alok Srivastava, MD FRACP, FRCPA, Aby Abraham, MD DM, Poonkuzhali Balasubramanian, MSc, Biju George, DM, Vikram Mathews, MD

Blood (2018) 132 (Supplement 1): 666.

https://doi.org/10.1182/blood-2018-99-114406

Published: 2018

Journal Articles

Assessing Patient-Reported Outcomes in People with Myelodysplastic Syndromes: Can a Customized Selection of Items from the EORTC Library Enhance the EORTC QLQ-C30?

Jill A Bell, PhD, Farrah A Pompilus, Anna Christian, MPH, Flora Mazerolle, MSc, Fatima Scipione, Rafael Bejar, MD PhD, Aaron Galaznik, PhD, Robert J. Fram, MD, Douglas V. Faller, MD PhD, Stefan Cano, PhD CPsychol, AFBPsS, Antoine Regnault, PhD

Blood (2018) 132 (Supplement 1): 4856.

https://doi.org/10.1182/blood-2018-99-116977

Published: 2018

Journal Articles

Haplo-Identical Transplants Using Post Transplant Cyclophosphamide (PTCy) Are Associated with Good Outcomes If Transplanted with Early Disease - a Single Centre Analysis from India

Biju George, DM, Aby Abraham, MD DM, Anu Korula, MD DM, Anup Joseph Devasia, MD DM, Kavitha M Lakshmi, MSc, Fouzia N., DNB, DM, Uday Prakash Kulkarni, MD DM, Alok Srivastava, MD FRACP, FRCPA, Vikram Mathews, MD

Blood (2018) 132 (Supplement 1): 4652.

https://doi.org/10.1182/blood-2018-99-118239

Published: 2018

Journal Articles

Very Long Term Follow-up Data of Pediatric Acute Promyelocytic Leukemia Treated with Upfront Arsenic-Trioxide Based Regimens

Fouzia N., DNB, DM, Anu Korula, MBBS, MD DM, Anup Joseph Devasia, MD DM, Uday Prakash Kulkarni, MD DM, Yasir Jeelani Samoon, MDDM, Thenmozhi Mani, PhD, Jeyaseelan Lakshmanan, PhD, Alok Srivastava, MD FRACP, FRCPA, Aby Abraham, MD DM, Poonkuzhali Balasubramanian, MSc, Biju George, DM, Vikram Mathews, MD

Blood (2018) 132 (Supplement 1): 1400.

https://doi.org/10.1182/blood-2018-99-114393

Published: 2018

Journal Articles

Pembrolizumab in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): Data from the Keynote-013 and Keynote-170 Studies

Blood (2018) 132 (Supplement 1): 228.

https://doi.org/10.1182/blood-2018-99-110220

Published: 2018

Journal Articles

Characterization and Genotype-Phenotype Correlation of Fanconi Anemia Patients in Israel

Orna Steinberg Shemer, MD MSc, Tracie Goldberg, MD, Joanne Yacobovich, MD, Carina Levin, MDPhD, Ariel Koren, MD, Shoshana Revel-Vilk, MD, Tal Ben-Ami, MD, Amir A Kuperman, MD, Vered Shkalim, MD, Amos Toren, MD PhD, Joseph Kapelushnik, Ayelet Ben-Barak, MD, Hagit Miskin, MD, Tanya Krasnov, MSc, Sharon Noy-Lotan, PhD, Orly Dgany, PhD, Hannah Tamary, MD

Blood (2017) 130 (Supplement 1): 1182.

https://doi.org/10.1182/blood.V130.Suppl_1.1182.1182

Published: 2017

Journal Articles

Donor Telomere Length Influences Engraftment and Outcome in Aplastic Anemia Patients Undergoing Matched Related Stem Cell Transplantation

Aruna Barade, M.Tech, Anu Korula, MD DM, Nisham PN, MD DM, Kavitha M Lakshmi, MSc, Uday Prakash Kulkarni, MD DM, Anup Devasia, MDDM, Aby Abraham, MD DM, Alok Srivastava, MD, Vikram Mathews, MD DM, Eunice Sindhuvi Edison, PhD, Biju George, MDDM

Blood (2017) 130 (Supplement 1): 1184.

https://doi.org/10.1182/blood.V130.Suppl_1.1184.1184

Published: 2017

Journal Articles

Efficacy and Safety of Pembrolizumab in Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (rrPMBCL): Updated Analysis of the Keynote-170 Phase 2 Trial

Pier Luigi Zinzani, MD, Catherine Thieblemont, MD PhD, Vladimir Melnichenko, Krimo Bouabdallah, Jan Walewski, MD PhD, Alejandro Majlis, MD, Laura Fogliatto, MD, Dolores Caballero, MD PhD, Beth Christian, MD, Zafer Gulbas, MD, Muhit Özcan, MD, Gilles Andre Salles, MD PhD, Margaret A. Shipp, MD, Arkendu Chatterjee, Robert J Orlowski, Arun Balakumaran, MD PhD, Philippe Armand, MD PhD

Blood (2017) 130 (Supplement 1): 2833.

https://doi.org/10.1182/blood.V130.Suppl_1.2833.2833

Published: 2017

Journal Articles

Clonal Cytogenetic Abnormalities in Myeloid Neoplasms Arising from Fanconi Anemia — a Single Center Study from India

Nancy Beryl Janet Arthur, MRCPath, MS, MSc, Vivi M Srivastava, MD, Gaurav Joshi, M.Sc, Anu Korula, MD DM, Anup Joseph Devasia, MD DM, Nisham PN, MD DM, Uday Prakash Kulkarni, MD DM, Alok Srivastava, MD, Vikram Mathews, MD DM, Shaji Ramachandran Velayudhan, M.Sc., PhD, Biju George, MDDM

Blood (2017) 130 (Supplement 1): 4956.

https://doi.org/10.1182/blood.V130.Suppl_1.4956.4956

Published: 2017

Journal Articles

Outcomes of Patients with Primary Refractory Mantle Cell Lymphoma, a Single Center Retrospective Study

David A Bond, MD, Ying Huang, MA, MS, Beth Christian, MD, Kami J. Maddocks, MD

Blood (2017) 130 (Supplement 1): 1503.

https://doi.org/10.1182/blood.V130.Suppl_1.1503.1503

Published: 2017

Journal Articles

a Phase I Study of BKM120 (Buparlisib) and Rituximab in Patients with Relapsed or Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (NHL)

Kami J. Maddocks, MD, Jonathon B. Cohen, MD, Ying Huang, MA, MS, Beth A Christian, MD, Don M Benson, MD PhD, Jeffrey Jones, MD MPH, Christopher Flowers, MD MS, Leonard T. Heffner, MD, Cynthia Jenkins, RN, Jennfer Sexton, MHA, CCRC, Alison Neal, MPH, Melissa Kives, MPH, Kristie A. Blum, MD

Blood (2016) 128 (22): 1776.

https://doi.org/10.1182/blood.V128.22.1776.1776

Published: 2016

Journal Articles

Management and Outcomes of Atrial Fibrillation in Patients Receiving Ibrutinib for Hematologic Malignancies at a Single Center

Tracy E Wiczer, PharmD, BCOP, Lauren B Levine, PharmD, BCOP, Jessica Brumbaugh, Jessica Coggins, Qiuhong Zhao, MS, Amy S. Ruppert, MAS, Anli McCoy, PharmD, Kami J. Maddocks, MD, Beth A Christian, MD, Kerry A. Rogers, MD, Leslie Andritsos, MD, Samantha Jaglowski, MD MPH, Steven M Devine, MD, Pierluigi Porcu, MD, Jennifer A. Woyach, MD, Jeffrey Jones, MD MPH, Michael R. Grever, MD, John C. Byrd, MD, Farrukh T. Awan

Blood (2016) 128 (22): 2040.

https://doi.org/10.1182/blood.V128.22.2040.2040

Published: 2016

Journal Articles

Major Bleeding Complications Among Patients Treated with Ibrutinib and Concomitant Antiplatelet, Anticoagulant, or Supplemental Therapy

Aaron Pavlik, PharmD, Hallie Barr, PharmD, BCOP, Emily Dotson, PharmD, BCOP, John C. Byrd, MD, Kristie A. Blum, MD, Farrukh T. Awan, Jennifer A. Woyach, MD, Kami J. Maddocks, MD, Beth A Christian, MD, Jeffrey Jones, MD MPH

Blood (2016) 128 (22): 4387.

https://doi.org/10.1182/blood.V128.22.4387.4387

Published: 2016

Journal Articles

A Phase I Study of BKM120 (Buparlisib) and Rituximab in Patients with Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma (NHL)

Kami J. Maddocks, MD, Jonathon B. Cohen, MD, Beth A Christian, MD, Don M Benson, MD PhD, Kristie A. Blum, MD

Blood (2015) 126 (23): 5114.

https://doi.org/10.1182/blood.V126.23.5114.5114

Published: 2015

Journal Articles

Updated Results of a Phase I Study of Ibrutinib and Lenalidomide in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma

Beth A Christian, MD, John G. Kuruvilla, MD, Sonali M. Smith, MD, Pierluigi Porcu, MD, Kami J. Maddocks, MD, Amy S. Ruppert, MAS, John C Byrd, MD, Michael R. Grever, MD, Kristie A. Blum, MD

Blood (2015) 126 (23): 3983.

https://doi.org/10.1182/blood.V126.23.3983.3983

Published: 2015

NARROW

Brentuximab Vedotin and Nivolumab for Relapsed or Refractory Classic Hodgkin Lymphoma: Long-Term Follow-up Results from the Single-Arm Phase 1/2 Study

Results of a Phase I Study of Obinutuzumab, Venetoclax, and Lenalidomide in Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma

A Phase I Study of Nivolumab and Lenalidomide in Relapsed/ Refractory B Cell Lymphoma

Brentuximab Vedotin (BV) and Lenalidomide (Len) in Relapsed and Refractory (r/r) Cutaneous (CTCL) and Peripheral (PTCL) T-Cell Lymphomas; A Planned Interim Analysis of Phase II Trial

Preliminary Results of a Phase I Study of Obinutuzumab, Venetoclax, and Lenalidomide in Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma

Management of Relapse in Acute Promyelocytic Leukemia Treated with Upfront Arsenic Trioxide Based Regimens

Assessing Patient-Reported Outcomes in People with Myelodysplastic Syndromes: Can a Customized Selection of Items from the EORTC Library Enhance the EORTC QLQ-C30?

Haplo-Identical Transplants Using Post Transplant Cyclophosphamide (PTCy) Are Associated with Good Outcomes If Transplanted with Early Disease - a Single Centre Analysis from India

Very Long Term Follow-up Data of Pediatric Acute Promyelocytic Leukemia Treated with Upfront Arsenic-Trioxide Based Regimens

Pembrolizumab in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): Data from the Keynote-013 and Keynote-170 Studies

Characterization and Genotype-Phenotype Correlation of Fanconi Anemia Patients in Israel

Donor Telomere Length Influences Engraftment and Outcome in Aplastic Anemia Patients Undergoing Matched Related Stem Cell Transplantation

Efficacy and Safety of Pembrolizumab in Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (rrPMBCL): Updated Analysis of the Keynote-170 Phase 2 Trial

Clonal Cytogenetic Abnormalities in Myeloid Neoplasms Arising from Fanconi Anemia — a Single Center Study from India

Outcomes of Patients with Primary Refractory Mantle Cell Lymphoma, a Single Center Retrospective Study

a Phase I Study of BKM120 (Buparlisib) and Rituximab in Patients with Relapsed or Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (NHL)

Management and Outcomes of Atrial Fibrillation in Patients Receiving Ibrutinib for Hematologic Malignancies at a Single Center

Major Bleeding Complications Among Patients Treated with Ibrutinib and Concomitant Antiplatelet, Anticoagulant, or Supplemental Therapy

A Phase I Study of BKM120 (Buparlisib) and Rituximab in Patients with Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma (NHL)

Updated Results of a Phase I Study of Ibrutinib and Lenalidomide in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only